These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14683462)

  • 1. Therapeutic implications for immunophilin ligands in the treatment of neurodegenerative diseases.
    Pong K; Zaleska MM
    Curr Drug Targets CNS Neurol Disord; 2003 Dec; 2(6):349-56. PubMed ID: 14683462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chemical biology of immunophilin ligands.
    Gaali S; Gopalakrishnan R; Wang Y; Kozany C; Hausch F
    Curr Med Chem; 2011; 18(35):5355-79. PubMed ID: 22087830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroimmunophilin ligands: evaluation of their therapeutic potential for the treatment of neurological disorders.
    Gold BG
    Expert Opin Investig Drugs; 2000 Oct; 9(10):2331-42. PubMed ID: 11060810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroimmunophilins: novel neuroprotective and neuroregenerative targets.
    Guo X; Dillman JF; Dawson VL; Dawson TM
    Ann Neurol; 2001 Jul; 50(1):6-16. PubMed ID: 11456311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of immunophilin ligands by quantitative analysis of neurofilament expression and neurite outgrowth in cultured neurons and cells.
    Liu D; McIlvain HB; Fennell M; Dunlop J; Wood A; Zaleska MM; Graziani EI; Pong K
    J Neurosci Methods; 2007 Jul; 163(2):310-20. PubMed ID: 17490751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunophilins: Structures, Mechanisms and Ligands.
    Harikishore A; Yoon HS
    Curr Mol Pharmacol; 2015; 9(1):37-47. PubMed ID: 25986569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunophilins: neuroprotective agents and promoters of neural regeneration].
    Udina E; Navarro X
    Neurologia; 2002 Apr; 17(4):200-13. PubMed ID: 11940408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimmunophilin ligands exert neuroregeneration and neuroprotection in midbrain dopaminergic neurons.
    Guo X; Dawson VL; Dawson TM
    Eur J Neurosci; 2001 May; 13(9):1683-93. PubMed ID: 11359520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophilin dysfunction and neuropathology.
    Park HJ; Rosado JA; Redondo PC; Cho YS
    Curr Med Chem; 2011; 18(35):5398-407. PubMed ID: 22087832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural roles of immunophilins and their ligands.
    Sabatini DM; Lai MM; Snyder SH
    Mol Neurobiol; 1997 Oct; 15(2):223-39. PubMed ID: 9396011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FKBP family proteins: immunophilins with versatile biological functions.
    Kang CB; Hong Y; Dhe-Paganon S; Yoon HS
    Neurosignals; 2008; 16(4):318-25. PubMed ID: 18635947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunophilins: their properties and their potential role in therapeutic drug monitoring.
    Soldin SJ
    Ther Drug Monit; 2000 Feb; 22(1):44-6. PubMed ID: 10688257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophilin ligands and GDNF enhance neurite branching or elongation from developing dopamine neurons in culture.
    Costantini LC; Isacson O
    Exp Neurol; 2000 Jul; 164(1):60-70. PubMed ID: 10877916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential control of glucocorticoid receptor hormone-binding function by tetratricopeptide repeat (TPR) proteins and the immunosuppressive ligand FK506.
    Davies TH; Ning YM; Sánchez ER
    Biochemistry; 2005 Feb; 44(6):2030-8. PubMed ID: 15697228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FK506 and its analogs - therapeutic potential for neurological disorders.
    Klettner A; Herdegen T
    Curr Drug Targets CNS Neurol Disord; 2003 Jun; 2(3):153-62. PubMed ID: 12769796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunophilin ligands: from immunosuppressants to neuroprotective drugs].
    Tanaka K; Ogawa N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Apr; 24(2):71-4. PubMed ID: 15164613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel immunophilin ligand: distinct branching effects on dopaminergic neurons in culture and neurotrophic actions after oral administration in an animal model of Parkinson's disease.
    Costantini LC; Chaturvedi P; Armistead DM; McCaffrey PG; Deacon TW; Isacson O
    Neurobiol Dis; 1998 Aug; 5(2):97-106. PubMed ID: 9746907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunophilin ligands in peripheral nerve regeneration.
    Behram Kandemir Y; Sarikcioglu L
    Folia Morphol (Warsz); 2015; 74(4):407-13. PubMed ID: 26620498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophilins in nervous system degeneration and regeneration.
    Avramut M; Achim CL
    Curr Top Med Chem; 2003; 3(12):1376-82. PubMed ID: 12871169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunophilins and their ligands: insights into survival and growth of human neurons.
    Avramut M; Achim CL
    Physiol Behav; 2002 Dec; 77(4-5):463-8. PubMed ID: 12526984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.